Is there a march from early food sensitization to later childhood allergic airway disease? Results from two prospective birth cohort studies-Reference-Cited by-同舟云学术

Is there a march from early food sensitization to later childhood allergic airway disease? Results from two prospective birth cohort studies

Published:2016-10-11 Issue:1 Volume:28 Page:30-37
ISSN:0905-6157
Container-title:Pediatric Allergy and Immunology
language:en
Short-container-title:Pediatr Allergy Immunol

Author:

Alduraywish Shatha A.¹²,Standl Marie³,Lodge Caroline J.¹,Abramson Michael J.⁴,Allen Katrina J.⁵,Erbas Bircan⁶,von Berg Andrea⁷,Heinrich Joachim³⁸,Lowe Adrian J.¹⁵,Dharmage Shyamali C.¹⁵

Affiliation:

1. Allergy and Lung Health Unit; Centre for Epidemiology and Biostatistics; Melbourne School of Population and Global Health; University of Melbourne; Melbourne Vic. Australia

2. Department of Family and Community Medicine; King Saud University; Riyadh Saudi Arabia

3. Institute of Epidemiology I; Helmholtz Zentrum München - German Research Center for Environmental Health; Neuherberg Germany

4. School of Public Health & Preventive Medicine; Monash University; Melbourne Vic. Australia

5. Murdoch Children's Research Institute; Department of Paediatrics; University of Melbourne; Royal Childrens' Hospital; Melbourne Vic. Australia

6. School of Psychology and Public Health; La Trobe University; Melbourne Vic. Australia

7. Marien-Hospital Wesel; Department of Pediatrics; Research Institute; Wesel Germany

8. Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine Unit; Paediatric Environmental Epidemiology; WHO Collaboration Centre for Occupational Health; University Hospital Munich; Munich Germany

Funder

Saudi Arabian Cultural Mission in Canberra, Australia

Helmholtz Zentrum Munich

Helmholtz-Zentrum für Umweltforschung

Research Institute at Marien-Hospital Wesel

Pediatric Practice, Bad Honnef

Federal Ministry for Environment

National Health and Medical Research Council

Sylvia and Charles Viertel Charitable Foundation

Pfizer

Boehringer Ingelheim

Novartis